Short answer
Sanara MedTech Inc. (SMTI) filed an 8-K current report with the SEC on October 16, 2026 reporting Item 8.01 (Other Events). FTC issued a Second Request on October 15, 2026, extending HSR review of MiMedx’s proposed acquisition.
Sanara MedTech Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- FTC issued a Second Request on October 15, 2026, extending HSR review of MiMedx’s proposed acquisition
- Merger waiting period now runs until 30 days after substantial compliance, unless extended or terminated earlier
- Closing remains contingent on FTC clearance and other merger conditions, increasing timing and completion uncertainty
- Sanara would become a wholly owned MiMedx subsidiary, subject to transaction completion
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Sanara MedTech Inc. 8-K filings
Get the next SMTI 8-K as it lands
Follow SMTI for push alerts, or ask the research agent what this filing means.